312 related articles for article (PubMed ID: 10051627)
1. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system.
Baumgarth N; Herman OC; Jager GC; Brown L; Herzenberg LA; Herzenberg LA
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2250-5. PubMed ID: 10051627
[TBL] [Abstract][Full Text] [Related]
2. Systemic and mucosal isotype-specific antibody responses in pigs to experimental influenza virus infection.
Heinen PP; van Nieuwstadt AP; Pol JM; de Boer-Luijtze EA; van Oirschot JT; Bianchi AT
Viral Immunol; 2000; 13(2):237-47. PubMed ID: 10893003
[TBL] [Abstract][Full Text] [Related]
3. Humoral immune responses during asthma and influenza co-morbidity in mice.
Doorley LA; LeMessurier KS; Iverson AR; Palipane M; Samarasinghe AE
Immunobiology; 2017 Dec; 222(12):1064-1073. PubMed ID: 28889999
[TBL] [Abstract][Full Text] [Related]
4. B-cell fate decisions following influenza virus infection.
Rothaeusler K; Baumgarth N
Eur J Immunol; 2010 Feb; 40(2):366-77. PubMed ID: 19946883
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of IgG2a-reactive autoantibodies from influenza virus-infected BALB/c mice.
Fazekas G; Rajnavölgyi E; Kurucz I; Sintár E; Kiss K; László G; Gergely J
Eur J Immunol; 1990 Dec; 20(12):2719-29. PubMed ID: 2269331
[TBL] [Abstract][Full Text] [Related]
6. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.
Khalil SM; Tonkin DR; Snead AT; Parks GD; Johnston RE; White LJ
J Virol; 2014 Aug; 88(16):9182-96. PubMed ID: 24899195
[TBL] [Abstract][Full Text] [Related]
7. Isotype profiles of anti-influenza antibodies in mice bearing the xid defect.
Reale MA; Bona CA; Schulman JL
J Virol; 1985 Feb; 53(2):425-9. PubMed ID: 3871483
[TBL] [Abstract][Full Text] [Related]
8. Co-stimulation With TLR7 Agonist Imiquimod and Inactivated Influenza Virus Particles Promotes Mouse B Cell Activation, Differentiation, and Accelerated Antigen Specific Antibody Production.
Li C; To KKW; Zhang AJX; Lee ACY; Zhu H; Mak WWN; Hung IFN; Yuen KY
Front Immunol; 2018; 9():2370. PubMed ID: 30369932
[TBL] [Abstract][Full Text] [Related]
9. An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency.
Shen C; Zhang M; Chen Y; Zhang L; Wang G; Chen J; Chen S; Li Z; Wei F; Chen J; Yang K; Guo S; Wang Y; Zheng Q; Yu H; Luo W; Zhang J; Chen H; Chen Y; Xia N
Theranostics; 2019; 9(1):210-231. PubMed ID: 30662563
[TBL] [Abstract][Full Text] [Related]
10. IgG isotype distribution of local and systemic immune responses induced by influenza virus infection.
Fazekas G; Rosenwirth B; Dukor P; Gergely J; Rajnavölgyi E
Eur J Immunol; 1994 Dec; 24(12):3063-7. PubMed ID: 7805734
[TBL] [Abstract][Full Text] [Related]
11. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
[TBL] [Abstract][Full Text] [Related]
12. Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene.
Bot A; Antohi S; Bot S; Garcia-Sastre A; Bona C
Int Immunol; 1997 Nov; 9(11):1641-50. PubMed ID: 9418125
[TBL] [Abstract][Full Text] [Related]
13. Influenza virus-specific antibody-secreting cells in the murine lung during primary influenza virus infection.
Jones PD; Ada GL
J Virol; 1986 Nov; 60(2):614-9. PubMed ID: 3773053
[TBL] [Abstract][Full Text] [Related]
14. Innate-like B cells and their rules of engagement.
Baumgarth N
Adv Exp Med Biol; 2013; 785():57-66. PubMed ID: 23456838
[TBL] [Abstract][Full Text] [Related]
15. A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice.
Babai I; Samira S; Barenholz Y; Zakay-Rones Z; Kedar E
Vaccine; 1999 Mar; 17(9-10):1239-50. PubMed ID: 10195637
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 7 agonist imiquimod in combination with influenza vaccine expedites and augments humoral immune responses against influenza A(H1N1)pdm09 virus infection in BALB/c mice.
Zhang AJ; Li C; To KK; Zhu HS; Lee AC; Li CG; Chan JF; Hung IF; Yuen KY
Clin Vaccine Immunol; 2014 Apr; 21(4):570-9. PubMed ID: 24521786
[TBL] [Abstract][Full Text] [Related]
17. Influenza virus-specific neutralizing IgM antibodies persist for a lifetime.
Skountzou I; Satyabhama L; Stavropoulou A; Ashraf Z; Esser ES; Vassilieva E; Koutsonanos D; Compans R; Jacob J
Clin Vaccine Immunol; 2014 Nov; 21(11):1481-9. PubMed ID: 25165027
[TBL] [Abstract][Full Text] [Related]
18. Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM.
Kris RM; Asofsky R; Evans CB; Small PA
J Immunol; 1985 Feb; 134(2):1230-5. PubMed ID: 2981265
[TBL] [Abstract][Full Text] [Related]
19. B Cell Activation and Response Regulation During Viral Infections.
Lam JH; Smith FL; Baumgarth N
Viral Immunol; 2020 May; 33(4):294-306. PubMed ID: 32326852
[TBL] [Abstract][Full Text] [Related]
20. Kinetics and isotype profile of rheumatoid factor production during viral infection: organ distribution of antibody secreting cells.
Fazekas G; Rosenwirth B; Dukor P; Gergely J; Rajnavölgyi E
Scand J Immunol; 1996 Sep; 44(3):273-84. PubMed ID: 8795722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
